SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-10-004474
Filing Date
2010-01-29
Accepted
2010-01-29 16:10:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 v172642_s3.htm S-3 386562
2 v172642_ex5.htm EX-5 33422
3 v172642_ex23-1.htm EX-23.1 4298
  Complete submission text file 0001144204-10-004474.txt   425687
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: S-3 | Act: 33 | File No.: 333-164591 | Film No.: 10559646
SIC: 2834 Pharmaceutical Preparations